www.fdanews.com/articles/197092-abbott-receives-emergency-use-authorization-for-covid-19-test
![abbott-logo.gif](https://www.fdanews.com/ext/resources/test/Drug-Images/abbott-logo.gif?t=1614806228&width=430)
Abbott Receives Emergency Use Authorization for COVID-19 Test
May 13, 2020
Abbott has been granted an Emergency Use Authorization (EUA) by the FDA for use of its coronavirus molecular test on its Alinity m molecular diagnostics analyzer.
The company is currently launching the Alinity m analyzer, which received FDA marketing clearance in March for use with its hepatitis C assay.
The automated platform can run up to 1,080 tests in 24 hours. In contrast, Abbott’s m 2000 RealTime system can only process 480 tests in a day.